期刊
ENDOCRINOLOGY
卷 142, 期 3, 页码 1290-1295出版社
ENDOCRINE SOC
DOI: 10.1210/en.142.3.1290
关键词
-
资金
- NIAMS NIH HHS [AR-32788, AR-42404] Funding Source: Medline
- NIDCR NIH HHS [DE-05413] Funding Source: Medline
Receptor activator of nuclear factor-kappaB ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-kappaB activation. RANK-L also prompts macrophages to develop the osteoclast phenotype. Although NF-kappaB is essential for osteoclast differentiation, it is not known whether RANK-L activates this transcription complex in osteoclast precursors. We report that RANK-L rapidly induces NF-kappaB activation in both authentic osteoclast precursors, namely bone marrow macrophages, and RAW 264.7 cells, a murine macrophage line also capable of RANK-L-mediated osteoclastogenesis. Supershift studies reveal the RANK-L-induced DNA binding moiety contains p50/p65, the most common NF-kappaB complex. Subcellular translocation of p50 and p65 subunits is confirmed by Western blots and immunofluorescence analysis. RANK-L activates NF-kappaB in both bone marrow macrophages and RAW 264.7 cells by serine phosphorylation of I kappaB alpha within 5 min, resulting in rapid I kappaB alpha degradation and resynthesis. Attesting to function, RANK-L treatment of RAW 264.7 cells transiently transfected with a plasmid containing NF-kappaB consensus elements linked to luciferase greatly enhances reporter activity. Our data suggest that activation of the NF-kappaB pathway is an integral component of RANK-L-induced osteoclast differentiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据